Structure-function analysis of PI3K signalling cascade base editing screens in cancer cells
Knowledge of protein structure and function underpins rational drug discovery, yet many targets lack known selectively druggable sites. Furthermore, the identification of secondary druggable sites offers a strategy to overcome drug resistance. Fragment-based drug discovery (FBDD) can identify new ligandable binding pockets, though how to triage those with the ability to exert biologically…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
